Skip to main content

Table 3 Sensitivity analysis for the association of primary outcomes whit LDL-C ≤ 70 vs. 70 < LDL-C < 100 in statin user patients (n = 7,383)

From: The prognostic role of the low and very low baseline LDL-C level in outcomes of patients with cardiac revascularization; comparative registry-based cohort design

 

No (LDL ≤ 70/ 70 < LDL ≤ 100)

Crude model

PSM model

Statin Users (n = 7,383)

Statin non-users (n = 2,835)

HR (95% CI)

P value

HR (95% CI)

P value

All-cause mortality

369 (12.1%)/ 441 (10.2%)

224 (18.1%)/ 256 (16.1%)

1.239 (1.079–1.423)

0.002

1.207 (1.042–1.336)

0.018

MACCE

676 (22.1%)/ 900 (20.8%)

410 (33.1%)/ 478 (30.0%)

1.124 (1.017–1.242)

0.022

1.114 (0.996–1.246)

0.065

  1. MACCE: major adverse cardiac and cerebrovascular events, HR: hazard ratio, CI: confidence interval